A protocol for a randomised controlled, double-blind feasibility trial investigating fluoxetine treatment in improving memory and learning impairments in patients with mesial temporal lobe epilepsy: Fluoxetine, Learning and Memory in Epilepsy (FLAME trial). (2019)
Attributed to:
MRC Centre for Neuropsychiatric Genetics and Genomics
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1186/s40814-019-0474-x
PubMed Identifier: 31321071
Publication URI: http://europepmc.org/abstract/MED/31321071
Type: Journal Article/Review
Volume: 5
Parent Publication: Pilot and feasibility studies
ISSN: 2055-5784